within Pharmacolibrary.Drugs.ATC.C;

model C07FB07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.88,
    Cl             = 0.25,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.17,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Bisoprolol and amlodipine is a fixed-dose combination drug used in the management of hypertension and angina pectoris. Bisoprolol is a selective beta-1 adrenergic blocker, while amlodipine is a long-acting calcium channel blocker. The combination is approved and widely used to achieve better blood pressure control in adult patients.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for healthy adults after oral administration, based on literature values for monotherapy of bisoprolol and amlodipine due to lack of published population PK models specific for the fixed-dose combination.</p><h4>References</h4><ol><li><p>Kawano, Y, et al., &amp; Mano, Y (2021). Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users. <i>Biological &amp; pharmaceutical bulletin</i> 44(5) 611â€“619. DOI:<a href=&quot;https://doi.org/10.1248/bpb.b20-00791&quot;>10.1248/bpb.b20-00791</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33952817/&quot;>https://pubmed.ncbi.nlm.nih.gov/33952817</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07FB07;
